Skip to content

Insulin therapy in critically ill children with hyperglycemia: clinical and biochemical characteristics.

Insulin therapy in critically ill children with hyperglycemia: clinical and biochemical characteristics.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27655
Enrollment
60
Registered
2010-07-02
Start date
2006-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperglycemia, insulin sensitivity , critical illness, child, PICU Hyperglycemie, insuline gevoeligheid, ernstige ziekte, kind, PICU

Interventions

Anthropometric measurements are taken on the day of admission. Blood glucose measurements are obtained as soon as possible after admission. In case of hyperglycemia >8 mmol/L (>145 mg/dL) measurements

Sponsors

ErasmusMC Rotterdam, Sophia Childrens Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Critically ill children aged 2 weeks to 18 years consecutively admitted to the PICU of the Erasmus MC-Sophia Children’s Hospital with hyperglycemia (defined as blood glucose level exceeding the value of 8 mmol/L (>145 mg/dL)) at any time during admission meeting the criteria for insulin treatment.

Exclusion criteria

Exclusion criteria: Children with diabetes mellitus are excluded.

Design outcomes

Primary

MeasureTime frame
Endogenous and exogenous factors influencing the endogenous insulin response to hyperglycemia.

Secondary

MeasureTime frame
Endogenous and exogenous factors influencing the duration of insulin therapy.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)